RAC1 and sarcoma: The oncogenic, activating Rac1 N92I mutation was discovered in the human sarcoma cell line HT1080 [20] and the C157Y mutation was discovered in patients with cranial malformations and has, as yet, unclear effects on Rac1 activity [20, 27].